Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device

iBiopsy LCS CADe/CADx SaMD could significantly contribute to eliminating barriers to the widespread adoption of lung cancer screening programs and save the lives of millions of patients

Related Keywords

United States ,Cade Cadx ,Cade Cadx Software As Medical Device Sa ,Drug Administration ,Median Technologies ,United States Food ,Biopsy Lung Cancer Screening ,Medical Device ,Fredrik Brag ,